Predictors of mortality post-gastrostomy in motor neuron disease patients

被引:2
作者
Yang, Jie [1 ,2 ]
Zhao, Yun [1 ]
Soares, Mario [1 ]
Needham, Merrilee [3 ,4 ,5 ]
Begley, Andrea [1 ]
Calton, Emily [1 ,6 ,7 ]
机构
[1] Curtin Univ, Fac Hlth Sci, Curtin Sch Populat Hlth, Kent St, Perth, WA 6102, Australia
[2] Fiona Stanley Hosp, Dept Nutr & Dietet, Perth, WA, Australia
[3] Fiona Stanley Hosp, Dept Neurol, Perth, WA, Australia
[4] Univ Notre Dame, Fac Med, Perth, WA, Australia
[5] Murdoch Univ, Ctr Mol Med & Innovat Therapeut CMMIT, Perth, WA, Australia
[6] Curtin Univ, Fac Hlth Sci, Sch Allied Hlth, Perth, WA, Australia
[7] Harry Perkins Inst, South Metropolitan Hlth Serv, Murdoch, WA, Australia
关键词
gastrostomy; motor neuron disease; predictor; short survival; weight; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; AMYOTROPHIC-LATERAL-SCLEROSIS; SURVIVAL; ALS;
D O I
10.1002/mus.28245
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction/AimsMotor neuron disease (MND) is a progressive neurodegenerative condition with a limited life expectancy. There is very little data on mortality and its associated factors beyond 30 days following gastrostomy. We explored the demographic, clinical, and nutritional predictors for early mortality at 30, 90, and 180 days following gastrostomy in these patients.MethodsThis was a retrospective study involving 94 MND patients in Western Australia who underwent gastrostomy between 2015 and 2021. Patients were divided into two groups based on mortality at 30, 90, and 180 days post-gastrostomy. T-test (or Mann-Whitney), chi-square test and Fisher's exact test were used for detecting between-group differences in various factors. Multivariable logistic regression was used to identify factors associated with post-gastrostomy mortality at 90 and 180 days.ResultsNo mortality was attributable to gastrostomy-related complications. Lower forced vital capacity (FVC) (p = .039) and greater weight loss (%) (p = .022) from diagnosis to gastrostomy were observed in those who died within 30 days post-gastrostomy. Older age (p = .022), male sex (p = .041), lower FVC (p = .04), requiring but not tolerating noninvasive ventilation (p = .035), and greater weight loss (%) (p = .012) were independent predictors of 90-day post-gastrostomy mortality. However, only older age (p = .01) and greater weight loss (p = .009) were predictors of mortality at 180 days post-gastrostomy.DiscussionOur data indicated that mortality at 90 and 180 days was influenced by the weight loss (%) from diagnosis to gastrostomy, highlighting the importance of nutritional care in the MND population. Gastrostomy placement prior to substantial weight loss may reduce the risk of weight loss-associated mortality and warrants further investigation. This retrospective study explored the factors associated with mortality in MND patients at 30, 90, and 180 days post-gastrostomy. The percentage of weight loss from diagnosis to gastrostomy was associated with mortality at 30, 90, and 180 days, highlighting the importance of nutritional care in the MND population. image
引用
收藏
页码:1010 / 1017
页数:8
相关论文
共 50 条
[31]   Mortality Trend and Predictors of Mortality in Dysphagic Stroke Patients Postpercutaneous Endoscopic Gastrostomy [J].
Jiang YueLong ;
Ruberu Nyoka ;
Liu XinSheng ;
Xu YingHua ;
Zhang ShuTian ;
Chan Daniel KY .
中华医学杂志英文版, 2015, 128 (10) :1331-1335
[32]   Increase in motor neuron disease mortality in Spain: Temporal and geographical analysis (1990-2005) [J].
Alonso, Veronica ;
Villaverde-Hueso, Ana ;
Hens, Manuel J. ;
Morales-Piga, Antonio ;
Abaitua, Ignacio ;
Posada de la Paz, Manuel .
AMYOTROPHIC LATERAL SCLEROSIS, 2011, 12 (03) :192-198
[33]   Optimizing the noninvasive ventilation pathway for patients with amyotrophic lateral sclerosis/motor neuron disease: a systematic review [J].
Baxter, Susan Kathryn ;
Johnson, Maxine ;
Clowes, Mark ;
O'brien, David ;
Norman, Paul ;
Stavroulakis, Theocharis ;
Bianchi, Stephen ;
Elliott, Mark ;
Mcdermott, Christopher ;
Hobson, Esther .
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2019, 20 (7-8) :461-472
[34]   Blood glutamate levels in patients with motor neuron disease [J].
Babu, GN ;
Bawari, M ;
Mathur, VN ;
Kalita, J ;
Misra, UK .
CLINICA CHIMICA ACTA, 1998, 273 (02) :195-200
[35]   Notch Signalling in the Hippocampus of Patients With Motor Neuron Disease [J].
Gomez-Pinedo, Ulises ;
Galan, Lucia ;
Matias-Guiu, Jordi A. ;
Pytel, Vanesa ;
Moreno, Teresa ;
Guerrero-Sola, Antonio ;
Matias-Guiu, Jorge .
FRONTIERS IN NEUROSCIENCE, 2019, 13
[36]   Epidemiological characteristics of motor neuron disease in Chinese patients [J].
Cui, F. ;
Liu, M. ;
Chen, Y. ;
Huang, X. ;
Cui, L. ;
Fan, D. ;
Pu, C. ;
Lu, J. ;
Zhou, D. ;
Zhang, C. ;
Yan, C. ;
Li, C. ;
Ding, X. ;
Liu, Y. ;
Li, X. ;
Jiang, Y. ;
Zhang, J. ;
Shang, H. ;
Yao, X. ;
Ding, Y. ;
Niu, Q. ;
Wang, L. .
ACTA NEUROLOGICA SCANDINAVICA, 2014, 130 (02) :111-117
[37]   Prevalence of multimorbidity and its impact on survival in people with motor neuron disease [J].
Glasmacher, Stella A. ;
Kearns, Patrick K. A. ;
Larraz, Juan ;
Stirland, Lucy ;
Mehta, Arpan R. ;
Newton, Judith ;
Weir, Christopher J. ;
Chandran, Siddharthan ;
Pal, Suvankar .
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (08) :2756-2765
[38]   The natural history of motor neuron disease: Assessing the impact of specialist care [J].
Aridegbe, Tomi ;
Kandler, Rosalind ;
Walters, Stephen J. ;
Walsh, Theresa ;
Shaw, Pamela J. ;
McDermott, Christopher J. .
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2013, 14 (01) :13-19
[39]   Recent progress in the genetics of motor neuron disease [J].
Finsterer, Josef ;
Burgunder, Jean-Marc .
EUROPEAN JOURNAL OF MEDICAL GENETICS, 2014, 57 (2-3) :103-112
[40]   Motor Neuron Disease: Pathophysiology, Diagnosis, and Management [J].
Foster, Laura A. ;
Salajegheh, Mohammad Kian .
AMERICAN JOURNAL OF MEDICINE, 2019, 132 (01) :32-37